The study comes months after the Advisory Committee on Immunization Practices (ACIP) voted in December 2025 to replace its ...
The sneaky virus poses serious health threats if it goes on to become a chronic disease. Clinical trial results suggest a new drug may cure 1 in 5 of those cases.
Significantly more patients with chronic hepatitis B virus infection achieved functional cure at week 72 after treatment with ...
A single hepatitis B injection set off a lasting immune response, and two patients reached a functional cure that held for ...
A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver ...
The findings supporting bepiroversen were deemed a “historic moment” by physicians and validate a drug that has “clear ...
A major clinical trial found that one in five people with chronic hepatitis B could control the virus without further ...
Most people recover from the infection, but it poses great risks for those who don’t. A new drug may cure 1 in 5 of these ...
Vaccination against hepatitis B is a common recommendation, but what exactly is it preventing? HHS Secretary Robert F. Kennedy Jr. and his advisory group plan to meet this week to discuss and vote on ...
10d
How a new drug shows promise as a 'functional cure' for Long Island's chronic hepatitis B patients
In about 20% of the drug's recipients, the virus remained undetectable for at least six months after all treatments were ...
Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping ...
New research implies that a first-of-its-kind drug for hepatitis B could allow some patients to stop treatment without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results